Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-026123
Filing Date
2019-12-13
Accepted
2019-12-13 15:00:53
Documents
1
Period of Report
2019-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO CURRENT REPORT f8k112919a1_wizepharma.htm 8-K/A 31175
  Complete submission text file 0001213900-19-026123.txt   32468
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-52545 | Film No.: 191284403
SIC: 2834 Pharmaceutical Preparations